Correlation Between Bionoid Pharma and City View
Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and City View at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and City View into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionoid Pharma and City View Green, you can compare the effects of market volatilities on Bionoid Pharma and City View and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of City View. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and City View.
Diversification Opportunities for Bionoid Pharma and City View
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bionoid and City is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and City View Green in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on City View Green and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with City View. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of City View Green has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and City View go up and down completely randomly.
Pair Corralation between Bionoid Pharma and City View
Given the investment horizon of 90 days Bionoid Pharma is expected to generate 0.51 times more return on investment than City View. However, Bionoid Pharma is 1.98 times less risky than City View. It trades about 0.02 of its potential returns per unit of risk. City View Green is currently generating about -0.18 per unit of risk. If you would invest 27.00 in Bionoid Pharma on October 10, 2024 and sell it today you would lose (1.00) from holding Bionoid Pharma or give up 3.7% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 95.45% |
Values | Daily Returns |
Bionoid Pharma vs. City View Green
Performance |
Timeline |
Bionoid Pharma |
City View Green |
Bionoid Pharma and City View Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bionoid Pharma and City View
The main advantage of trading using opposite Bionoid Pharma and City View positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, City View can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in City View will offset losses from the drop in City View's long position.Bionoid Pharma vs. Air Lease | Bionoid Pharma vs. Molson Coors Brewing | Bionoid Pharma vs. Keurig Dr Pepper | Bionoid Pharma vs. Willis Lease Finance |
City View vs. Benchmark Botanics | City View vs. Speakeasy Cannabis Club | City View vs. BC Craft Supply | City View vs. Ravenquest Biomed |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
CEOs Directory Screen CEOs from public companies around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |